chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mother called to say that pt has temp of 99 left arm is hot to touch and swollen at site, also some axillary swelling.
Immediately after shot my eyes started feeling  wierd, and blurry. Over the next couple days I noticed my left eye wasn't centered. It was turned in toward right corner. My eye also began having spasms. In the next couple weeks my right eye also moved toward center, but not as bad as left eye. I went to eye dr. and she said I had swelling in eyes and gave me steroid eye drops. They helped but I had to go back a 2nd time for more drops. My eyes are better, but never compltely the same. I still need the drops. (Also note a nurse suggested I take an allergy medication after my 2nd shot. I did for about 10 days and my eyes didn't react as bad as with 1st shot.)
One of my new MAs was administering a flu vaccine to one of our patients. She realized that when she administered the flu shot to the patient, she had grabbed the high dose flu vaccine instead of giving her the regular dose. Patient did not appear harmed. MA notified the nurse, me, and then I notified my PA and quality department same day.
I experienced a headache and low grade fever about 36 hours after 2nd injection.  I also have a very itchy rash that developed after the first injection but did make any connection as it is on my hands, face and around my neckline.  The rash has gotten worse since the 2nd injection.  I am being treated to my dermatologist for the rash/itching.  I received a steroid injection, 21 days of Predinsone, Clobestasol Priopionate ointment (0.05%) and Hydrocortisone cream (2.5%) on March 22, 2021
I had a reaction felt as if something was in my throat and chest tightness difficult to breath.
mom called to say that 7 days p/vax pt had a reddened area lt deltoid area & was seen by MD & treated as an infect; MD did not think it was vax related but did not know the cause of infect
This spontaneous report as received from a nurse refers to an unspecified number patient of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with VARIVAX which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some time to get the VARIVAX information (patient identifiers, lot numbers, expiration dates and dates of vaccine administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range reported 2-5, units not reported) of unknown gender. On 29-SEP-2014, the patient was vaccinated with a dose of VARIVAX which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Patient's mother reported to us that patient had shoulder discomfort following injection and went to Urgent Care for a cortisone injection. Per mother the urgent care told her the vaccine was "given too high" and caused "bursitis and shoulder impingement".  Our office has not seen the patient for any kind of post vaccine/shoulder pain evaluation or follow up.
Developed swollen lymph node under right arm; This is a spontaneous report from a contactable nurse (patient). A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK5730) intramuscularly at right arm on 20Dec2020 at 10:15 a.m. at a single dose (dose number=1) for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient was not pregnant. Facility type vaccine was at hospital. No other vaccine in four weeks. The patient developed swollen lymph node under right arm on 21Dec2020 at 11:00 a.m. The event was reported as non-serious. with outcome of recovering. No treatment received for the event. No COVID-19 diagnosed prior vaccination and no COVID-19 tested post vaccination. No known allergies (no allergies to medications, food, or other products).  No follow-up attempts are possible. No further information is expected.
PATIENT REPORTED TODAY  (7/1/2020) THAT HE STARTED HAVING ARRHYTHMIA AND DIFFICULTY BREATHING LATER IN THE EVENING AFTER THE VACCINE AROUND 7PM, AND HAD EXTREME FATIGUE THAT CONTINUED ON THE NEXT DAY AS WELL
Developed body aches 2 days after vaccination, fever on day 3 and on day 4 was admitted to hospital with pneumonia.
Short term memory less; Very strong pain the arm (could not move it or pick up any weight); Continuous runny watery nose; Excesive sweating/I sweat a lot while sleeping but I did not have a fewer.; This is a spontaneous report from a contactable consumer (patient herself). A 27-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EN6200) via an unspecified route of administration in left arm on 02Mar2021 04:30PM at single dose for COVID-19 immunization. Relevant medical history was not reported. The patient had no COVID prior vaccination. Concomitant medications included iron. The patient was not administered with any vaccine in four weeks. On 02Mar2021 04:30PM the patient had very strong pain in the arm (could not move it or pick up any weight), continuous runny watery nose, excessive sweating (during the next two nights after getting vaccine, so on 02Mar2021 and 03Mar2021, the patient sweat a lot while sleeping but with no fever). In addition, about 72 hours after getting vaccine, the patient had short term memory loss (she would read something immediately forgetting was she just read (lasting for about 30-45 minutes). The patient did not receive treatment and was not tested for COVID after vaccination. Events lasted about 72 hours after getting vaccine and resolved in Mar2021.  No follow-up attempts are possible. No further information is expected.
Patient reports chills, fatigue, aches, diarrhea, and dizziness/imbalance approximately 24 hours after vaccination.  Patient advised to see primary care physician given his balance issues/concerns.  Given that patient was referred to make an appointment to see PCP, I am submitting a VAERS report on that basis.
tested positive for covid; This is a spontaneous report from a contactable nurse (patient's daughter) via medical information team. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), first dose via an unspecified route of administration on 03Mar2021 (lot number and expiration date were not reported) as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient tested positive for covid on Monday, 08Mar2021. The patient have their second vaccination scheduled for 24Mar2021. The nurse wanted to know if the patient tested negative in two weeks could she take the second vaccination. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Based on the known safety profile of the vaccine BNT16B2, a temporal relation between the event Covid-19 and the administration of the vaccine cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events.  Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Headache, Fever, Chiils,back pain, joint pain, pain at injection site Narrative:
It was the determination of the physician that member received a vaccine other than IPPD intradermally.  Member had redness and discomfort on the affected arm.  Member was retested with IPPD placed on right arm without adverse reaction.
Been feeling little under the weather today as wel; This non-serious case was reported by a consumer via sales rep and described the occurrence of unwell in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 08-JUN-2023, the patient received Shingrix. On 09-JUN-2023, 1 days after receiving Shingrix, the patient experienced unwell (Verbatim: Been feeling little under the weather today as wel). The outcome of the unwell was not resolved.   It was unknown if the reporter considered the unwell to be related to Shingrix.     It was unknown if the company considered the unwell to be related to Shingrix.   Additional Information: GSK receipt date: 12-JUN-2022 The patient stated that he/she already read on site, but nothing says how long do side effects should last. The patient got the shot on Thursday and definitely felt side effects on Friday and was been feeling little under the weather on the day of reporting as well.
This is a spontaneous report from a contactable physician via a sales representative. A male patient of an unspecified age and ethnicity received a single dose of TRUMENBA via an unspecified route of administration on an unspecified date. The patient medical history and concomitant medications were not reported. The patient experienced headache on an unspecified date. The outcome of the event was unknown. Follow-up (19JUN2015): Follow-up attempts completed. No further information expected.
This spontaneous report was received from a physician via an unspecified reporter referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 14-DEC-2015, the patient was vaccinated with a dose of PNEUMOVAX 23 "10Pk 0.5mL SD-PFS LLokwTip 10Pk" and  lot # L014876 with expiration date 13-JAN-2017 (route of administration and anatomical location were not reported), which was stored at a lowest recorded temperature of 32F (0 Celsius) for 104 hours; also there were reported temperatures of 34f (1.1 degrees C) and 48F (8.8 degrees C). The vaccine status was reported as excursion and the storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No concomitant therapies nor adverse effect were reported. No product quality complaint was involved.  This is one of several cases from the same reporter. Additional information has been requested.
redness, warm,  tenderness, swelling, itchiness on the left upper arm injection site
5 hours after vaccine had uncontrollable chills.  Temp was 103 7-8 hrs after vaccine.  1 hour after taking Motrin 600 mg had localized soreness 3 hours afterwards.  The next day, felt better - feel she has low grade fever (approximately 99-100).  No other sxs.  Fever up to 101 the following evening.
Small red macules face and urticarial lesions on back within 2-5 minutes. 1051 ZYRTEC 2.5 mg given. Vomited right after taking. 1100 ORAPRED 15 mg given, lesions resolved within 30 minutes. Large diarrhea stool several hours later.
Headache, NauseaVomiting, chills, body aches Narrative:
It was reported that a 44 year old female pt received a TD Adult vaccination on 08/28/2000. Reportedly within 30 mins after the injection the pt developed shakiness, heart racing, tightness in throat and headache. Treatment-observation only. Reportedly the pt recovered from this experience.
So bad - 100.3 temp  Flushing on face Rash on torso, front and back Insomnia Excessive emotionality and reflexive situational responses  Easily overwhelmed Mania, EXTREMELY MUCH crying for no reason It's been fun, y'all. It's exacerbated what seem to be already existing conditions because I am both very mentally and physically ill already.  I did physically attack my father and husband so that was not cool at all  , so yeah, increased anger  Way worse emotional effects after second dose
In afternoon after vaccine was received, noticed vaccine area was swollen, red and developing a rash.  Spot co tinier to grow next day. After two days or so it went away.  Wednesday 17th vaccine area very itchy and was red swollen and developed a rash again. Area continued to grow throughout day. Today Thursday still have area red swollen and rash.
Death; Kidney shutdown; This is a spontaneous report from a contactable consumer reporting for the mother. An 83-year-old female patient received bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration in arm, on 28Feb2021, as single dose, for COVID-19 immunisation. Medical history included unspecified ailments. Concomitant medications were not reported. The patient experienced kidney shutdown (medically significant) on 02Mar2021 with outcome of unknown and death (death, medically significant) on 14Mar2021. The cause of death was unknown. It was not reported if an autopsy was performed.  The information on the lot/batch number has been requested.; Reported Cause(s) of Death: Death
After the first shot, headache started the next morning and has not stopped, it gets worse with exercise, or work, goes up and down in intensity depending on what I am doing. After the second shot, the headache got worse. It pushed my borderline high blood pressure from 135/80 to 158/80 and now I am on blood pressure meds to bring it down. Ibuprofen 800 does nothing to the headache, it's just always there. It's over 2 months now, and I can't get rid of this headache.   Fingers and Toes also "ache", like a bone ache, weird feeling I have never had before, that also started the day after the first dose. I also got the fever, nausea, but those went away after 72 hrs. The headache and the finger/toe bone ache have not.
Deep aching pain at time of shot 8/12/05 which contiunes to date 10/25/05. Unable to to move arm unbearable pain which required emergency room visit on 9/3/05. Xray was taken pain meds Naproxen was given and refered to Ortho Clinic then to Physical Thrapy. This is week #11 still in pain, and have not regain full range of motion in arm(left).
This spontaneous report ws received from a pharmacist referring to a female patient of unknown age. Pertinent medical history and drug allergies were unspecified. On an unknown date the patient was vaccinated with ZOSTAVAX, 1 injection, subcutaneous (dose not reported). No other concomitant therapies reported. On an unknown date the patient reported that after receiving ZOSTAVAX, the patient was shaking. The physician told the patient to go to the Emergency Room. The patient attended the Emergency Room. No treatment was received for the adverse event. The suspect product was not reintroduced. The patient did recovered and was fine when she attended her follow up appointment with her physician.  The patient sought medical attention. The outcome of the event was reported as recovered/resolved. The causality of the event was unspecified. Additional information has been requested.
"Instantly" after getting the vaccination, pt. described his left eye "felt on fire".  His eye started watering . He later reported he had an "instant" migraine.  MD was called to evaluate. He was having no SOB, vitals were stable x 30 minutes.  He said he felt well to go home.  After he was home, he felt fatigued, SOB, had some chest pain, eye pain and migraine.  He went to bed and slept the night.  In the AM he awoke, still fatigues, eye pain.  Went to work and then sent home.  He spiked a fever to 102F.  His wife reported he was "barely responsive".  He was taken to ED.
Mother called clinic to report two days after receiving Covid-19 vaccine pt. experienced syncope during a sports practice.  Mother reports pt was taken to hospital where she was given IV fluids for "severe dehydration".
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A 19-year-old female patient received BNT162b2 (BNT162B2), on 01Apr2021 as dose 1, single (Lot number: EP6955) and on 21Apr2021 as dose 2, single (Batch/Lot number: unknown, Expiration Date: 30Jun2021) at the age of 18 years for Covid-19 immunisation; CoviD-19 vaccine mRNA (mRNA 1273) (MODERNA COVID-19 VACCINE), as dose 3 (booster), single (Lot number: 068H21A) for Covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Person that had COVID Vaccination; first two vaccination from Pfizer and the third booster was from Moderna and she have now got the COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: tested positive for COVID. (within two weeks). Therapeutic measures were not taken as a result of Covid-19. Clinical course: The Pfizer employee stated that he/she was reporting on behalf of someone, the patient name (daughter) (Initial captured as withheld in the tab). Employee stated that the reason for missing lot numbers of COVID-19 Vaccine Pfizer was that it looked like the first dose is EP6955 and second looked like, it is the same lot (further not clarified hence, not captured in tab). The employee had some details of the patient. The reporter stated that the patient had medical condition in past, but now she had recovered. The patient did not receive any other vaccines within four weeks prior to the vaccination. Regarding the treatment that the patient did not take medication. The reporter did not had the expiration date for the second dose. The reporter stated that the mailing address was withheld. This report was a product complaint report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Cutaneous skin reaction to injection, possibly suggestive at delay hypersensitivity reaction, particularly with second dose Adverse reaction first reported 9/2/21 and patient examined by provider that day
Chills, sore throat/dryness, rapid heart beat a few hours after receiving the vaccine
pt recv vax 19OCt98 & 20OCT98 exp blurred vision,next day exp diarrhea & weakness;then exp n/v, weakness, vomiting, nausea, needed help to walk;hosp until Tuesday for rhabdomyolysis r/t flu vax;pt stated enzyme attacked muscles in body;
Raised skin with a 3" diameter circle at site of injection, Initially 1" high and then caused frozen shoulder  On spot of injection causing limited range of motion that has not improved in 6 months.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 40 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "asthma" (unspecified if ongoing); "GAD" (unspecified if ongoing); "overweight" (unspecified if ongoing); "known allergies: penicililin" (unspecified if ongoing), notes: known_allergies penicililin. There were no concomitant medications. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: UNKNOWN. Therapeutic measures were taken as a result of covid-19, drug ineffective.  Clinical course: If vaccine received Yes. Other medication in 2weeks No. Anti viral details product=COVID 19 Treatment, brand=Pfizer, treatment start date=16May2022, treatment stop date=21May2022, covid vaccine details vaccine brand=Pfizer / BioNTech, vaccine brand unknown=False, vaccine administration date=22Oct2021, vaccine dose number=3, vaccine dose number unknown=False, vaccine location=Left arm, adverse event Experiencing a paxlovid rebound. As of now, my symptoms are: congestion, chills, no fever, and stomach cramps.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Mild headache around 15min after receding vaccine. Went away on its on by noon. I had slight swelling in arm when I was at home aroun 11:45a, soreness in muscle. Pain at injection site.  3/19/2021...right arm still sore, warmness in upper right arm. No other side effects. Still continues, soreness has gone down. Still tender on 3/28/2021. But has been subsiding. No other adverse reactions. My husband  had same injection, same lot # same day. Had a mild headache that subsided. Nothing more.
High fever (104 degrees), sneezing, cough, fatigue,  Pain in all extremities, joints, and muscles, confusion, dizziness,  Severe headache, sore throat, nausea, abdominal pain, diarrhea, chills (violent), ice cold extremities to touch.
No additional AEs were reported.; Medical assistant reported that a pregnant patient received a dose of GARDASIL 9 on 05/12/2022.; This spontaneous report was received from a medical assistant and refers to a female, pregnant patient of an unknown age. The patient's concomitant medications included insulin lispro (HUMALOG) and insulin glargine (LANTUS). There was no information about the patient's concurrent conditions, drug allergies or reactions and historical conditions provided.   The last menstrual period (LMP) was estimated on 28-OCT-2021. Estimated date of delivery (EDD) was 04-AUG-2022. The pregnancy outcome was lost to follow-up.   On an unknown date, the patient had urine pregnancy test and glycosylated hemoglobin (A1C) tests performed, however no results were reported.   On 12-MAY-2022, the patient was vaccinated with the first dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) injection (dose, route and site of administration, lot number and expiration date were not provided) for prophylaxis (exposure during pregnancy). No other adverse events were reported (no adverse event).
single supraclavicular swelling appearing 24 hours after ipsilateral intramuscular vaccine administration; This is a spontaneous report received from a contactable consumer (patient). A 48-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) intramuscularly in the right arm on 05Apr2021 at 14:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food or other product, had not been diagnosed with COVID-19 prior to vaccination and had not received any other vaccines in the four weeks prior to the COVID vaccine. Concomitant medications included lamotrigine from an unknown date for an unknown indication. The patient previously received the first dose of BNT162B2 (lot number unknown) on 15Mar2021 at 12:00 (at the age of 48-years-old) for COVID-19 immunisation. On 06Apr2021 the patient experienced single supraclavicular swelling which appeared 24 hours after ipsilateral intramuscular vaccine administration. No treatment was received for the events. The clinical outcome of single supraclavicular swelling appearing 24 hours after ipsilateral intramuscular vaccine administration was reported as not recovered. It was also reported that since vaccination the patient had not been tested for COVID-19.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Nausea, low-grade fever, soreness full  body, headache for a day and a half, chills